Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
08/2012
08/02/2012US20120196866 2-Oxo-1-Pyrrolidine Derivatives, Processes for Preparing Them and Their Uses
08/02/2012US20120196863 1,4 oxazines as bace1 and/or bace2 inhibitors
08/02/2012US20120196862 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196861 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012US20120196860 Triazine derivatives and their therapeutical applications
08/02/2012US20120196859 Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase
08/02/2012US20120196858 Method of promoting apoptosis and inhibiting metastasis
08/02/2012US20120196856 Aryl aminopyridine pde10 inhibitors
08/02/2012US20120196851 Wnt pathway antagonists
08/02/2012US20120196849 Compounds and compositions as hedgehog pathway modulators
08/02/2012US20120195930 Novel pyridine derivatives
08/02/2012US20120195857 Hepatitis C Virus Inhibitors
08/02/2012US20120194894 Electrochromic compound, electrochromic composition, and display element
08/02/2012DE112010001898T5 Insektizide Pyridinverbindungen Insecticides pyridine
08/02/2012CA2825779A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012CA2825684A1 Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
08/02/2012CA2825172A1 Indole derivative and pharmacologically acceptable salt of same
08/02/2012CA2825134A1 Indole derivative, and pharmacologically acceptable salt thereof
08/02/2012CA2824536A1 Protease activated receptor 2 (par2) antagonists
08/02/2012CA2823804A1 Novel tetrahydroquinoline derivatives
08/02/2012CA2822120A1 Substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481736A1 Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
08/01/2012EP2481735A1 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
08/01/2012EP2481732A1 Condensed ring compound and use thereof
08/01/2012EP2481729A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases
08/01/2012EP2480548A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480547A2 Indolizine inhibitors of 5-lipoxygenase
08/01/2012EP2480544A1 Compounds which selectively modulate the cb2 receptor
08/01/2012EP2480543A1 Piperidine and piperazine derivatives as smo antagonists
08/01/2012EP2480539A1 N-(1,2,5-oxadiazol-3-yl) benzamides and the use thereof as herbicides
08/01/2012EP2480537A1 Aminoquinazoline compounds for combating invertebrate pests
08/01/2012EP2480529A1 Indole derivatives as crac modulators
08/01/2012EP2480086A1 Novel dihydropyrimidin-2(1h)-one compounds as s-nitrosoglutathione reductase inhibitors
08/01/2012EP2265273B1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
08/01/2012EP2238132B1 Insecticidal compounds
08/01/2012EP2024347B1 Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
08/01/2012EP1931660B1 Phenyl-[1,2,4]-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
08/01/2012EP1888543B1 Apoptosis promoters
08/01/2012EP1871749B1 Selurampanel
08/01/2012EP1856098B1 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
08/01/2012EP1666472B1 Phenylacetic acid derivative, process for producing the same, and use
08/01/2012CN102625806A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/01/2012CN102625805A Compounds and compositions for treating cancer
08/01/2012CN102625799A Heterocyclic compounds and their uses
08/01/2012CN102617567A Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
08/01/2012CN102617561A 2-benzylthio benzene heterocyclic-fused derivative, preparation method thereof and medical application thereof
08/01/2012CN102617560A Preparation method of furilazole
08/01/2012CN102617548A Bicycloheteroaryl compounds as GPR Receptor stimulant, compositions and application thereof
08/01/2012CN102617445A Photosensitive compositions, curable compositions, novel compounds, photopolymerizable compositions, color filters, and planographic printing plate precursors
07/2012
07/31/2012US8232409 Heterocyclic benzimidazoles as TRPM8 modulators
07/31/2012US8232312 Substituted arylsulphonylglycines, the preparation thereof and the use thereof as pharmaceutical compositions
07/31/2012US8232299 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
07/31/2012US8232285 Quinazolinone compounds and methods of use thereof
07/31/2012US8232274 Pyridazinone derivatives useful as glucan synthase inhibitors
07/31/2012US8232273 Heterocyclic compounds and methods of use
07/31/2012US8231754 Coloring composition, thermal transfer recording ink sheet, thermal transfer recording method, color toner, inkjet ink, color filter, and dye compound
07/31/2012CA2565599C Substituted 2-quinolyl-oxazoles useful as pde4 inhibitors
07/31/2012CA2516186C Pyridine derivatives as fungicidal compounds
07/31/2012CA2503445C Methylene urea derivatives as raf-kinase inhibitors
07/26/2012WO2012100229A2 Compositions and methods for cardiovascular disease
07/26/2012WO2012100135A1 Picolinamide inhibitors of kinases
07/26/2012WO2012099317A1 Method for imaging zinc activation within a mitochondrion using a two-photon fluorescent probe, and method for manufacturing the two-photon fluorescent probe
07/26/2012WO2012099200A1 Pyrazole derivative
07/26/2012WO2012098505A1 2-methoxy-pyridin-4-yl derivatives
07/26/2012WO2012098217A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
07/26/2012WO2012098132A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012WO2012098070A1 Quinoline dyrk1 inhibitors
07/26/2012WO2012098064A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012WO2012098050A1 Methyltetrazole sulfides and sulfones
07/26/2012WO2012098049A1 Process for the preparation of statins in the presence of base
07/26/2012WO2012098048A1 Process for the preparation of diol sulfones
07/26/2012WO2012098033A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012WO2012097697A1 Organic amine salts of azilsartan, preparation method and use thereof
07/26/2012WO2012066488A3 Bridged spiro[2.4]heptane ester derivatives
07/26/2012WO2011097946A8 Oxazolidinone compounds containing ring-fused bicyclic ring, preparation method and use thereof
07/26/2012US20120190853 Benzoimidazolyl-pyrazine compounds for inflammation and immune-related uses
07/26/2012US20120190845 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
07/26/2012US20120190713 Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections
07/26/2012US20120190700 Novel 4-amino-n-hydroxy-benzamides for the treatment of cancer
07/26/2012US20120190695 Phenyloxadiazole derivatives as pgds inhibitors
07/26/2012US20120190682 Modulators for amyloid beta
07/26/2012US20120190681 Picolinamide inhibitors of kinases
07/26/2012US20120190680 Heteroaryl Amide Analogues
07/26/2012US20120190677 Novel tetrahydroquinoline derivatives
07/26/2012US20120190675 Azaspirohexanones
07/26/2012US20120190673 Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases
07/26/2012US20120190543 Pesticidal compositions
07/26/2012US20120189623 Cyclized derivatives as eg-5 inhibitors
07/26/2012US20120189539 Bcl-2/bcl-xl inhibitors and therapeutic methods using the same
07/26/2012CA2825124A1 Fused dihydrofurans as gpr119 modulators for the treatment of diabetes, obesity and related disorders
07/26/2012CA2824544A1 Picolinamide inhibitors of kinases
07/26/2012CA2824460A1 Azetidine derivatives useful for the treatment of metabolic and inflammatory diseases
07/26/2012CA2824316A1 Organic amine salts of azilsartan, preparation method and use thereof
07/26/2012CA2823780A1 Novel 4-amino-n-hydroxy-benzamides as hdac inhibitors for the treatment of cancer
07/26/2012CA2819158A1 1,4 oxazines as bace1 and/or bace2 inhibitors
07/26/2012CA2818470A1 2-methoxy-pyridin-4-yl derivatives
07/25/2012EP2479176A1 Method for preparation of iloperidone and crystallization method thereof
07/25/2012EP2479175A1 Compounds and methods for treating dyslipidemia
07/25/2012EP2479169A1 Synthesis of Enone Intermediate
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 647